Lipid management in Qatar in High CV-risk Patients: Why do we need novel therapeutics?
Lecture - Dec. 17, 2016 - Qatar - Dr. Hani Sabbour, Abu Dhabi, UAE - Master Class - PCSK9 Inhibiion in Clinical Lipid Management
This session is recorded at Master Class - PCSK9 Inhibition in Clinical Lipid Management
Dr Hani Sabbour is Consultant Cardiologist and Electrophysiologist -Clinical Professor of Cardiology, Cardiology Department Sheikh Khalifa Medical Center, Abu Dhabi , UAE
The meeting was sponsored by Sanofi Gulf
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.